Quarterly and annual results disclosed under 8-K Item 2.02.
Q32 Bio Inc. reported the quarter ended March 31, 2026 results: net income Net loss was $7.6 million, or $0.54 basic and diluted net loss per share, EPS $0.54 basic and diluted net loss per share.
“Net loss was $7.6 million, or $0.54 basic and diluted net loss per share, for the three months ended March 31, 2026, compared to net loss of $11.0 million, or $0.90 basic and diluted net loss per share, for the three months ended March 31, 2025.”
BLACKLINE, INC. reported first quarter ended March 31, 2026 results: revenue Total GAAP revenues of $183.2 million, net income GAAP net income attributable to BlackLine of $8.1 million, EPS $0.13 per diluted share. Guidance raised.
““BlackLine delivered a solid first quarter with accelerating revenue growth, operating leverage, and momentum from our platform strategy,” said Owen Ryan, CEO of BlackLine. “We are defining the future of the financial close with Agentic Financial Operations, turning our vision for trusted, auditable AI into commercial reality. The growing adoption of our Verity AI capabilities and Studio360 demonstrate that CFOs view BlackLine as the essential governance layer for the AI era. Driven by strong execution and a growing pipeline, we are raising our full-year outlook while continuing to deliver durable, profitable growth.” First Quarter 2026 Financial Highlights Total GAAP revenues of $183.2 million, an increase of 9.7% compared to the first quarter of 2025. GAAP operating margin of 3.4%, compared to 2.1% in the first quarter of 2025. Non-GAAP operating margin of 21.6%, compared to 20.9% in the first quarter of 2025. GAAP net income attributable to BlackLine of $8.1 million, or $0.13 per di”
Atkore Inc. reported 2026 full-year results: EPS $5.05 to $5.55. Guidance reaffirmed.
“Maintaining 2026 full-year Adjusted EBITDA outlook of $340 to $360 million, and; full-year Adjusted net income per diluted share outlook of $5.05 to $5.55”
Atkore Inc. reported fiscal 2026 second quarter ended March 27, 2026 results: revenue $731.4 million, net income a net loss of $124.1 million, EPS $(3.65) per diluted share.
“Atkore Inc. Announces Second Quarter 2026 Results • Net sales of $731.4 million, up 4.2% versus prior year • Net loss per diluted share decreased by $2.19 versus prior year to a net loss per share of $(3.65); Adjusted net income per diluted share decreased by $0.81 versus prior year to $1.23 • Net loss decreased by $74.0 million versus prior year to a net loss of $124.1 million”
DuPont de Nemours, Inc. reported the first quarter ended March 31, 2026 results: revenue $1,681, net income $150, EPS $0.36. Guidance raised.
“our shareholders,” Koch concluded. First Quarter 2026 Consolidated Results (1) Dollars in millions, except EPS 1Q’26 1Q’25 Change vs. 1Q’25 Organic Sales (2) vs. 1Q’25 Net sales $1,681 $1,612 4% 2% GAAP Income from continuing operations $150 $80 88% Operating EBITDA (2) $414 $360 15% Operating EBITDA margin (2) % 24.6 % 22.3 % 230 bps GAAP EPS from continuing”
Donnelley Financial Solutions, Inc. reported the first quarter ended March 31, 2026 results: revenue $205.5 million, net income $33.5 million, EPS $1.27 per diluted share.
“Inc. (NYSE: DFIN) (the “Company” or “DFIN”) today reported financial results for the first quarter of 2026. First-Quarter 2026 First-Quarter 2025 $ Change % Change Net Sales $205.5 million $201.1 million $4.4 million 2.2% Net Earnings $33.5 million $31.0 million $2.5 million 8.1% Adjusted EBITDA (a) $70.6 million $68.2 million $2.4 million 3.5% Operating Cash Flow”
Frontier Group Holdings, Inc. reported first quarter of 2026 results: revenue $ 992, net income $ (272), EPS $ (1.18). Guidance initiated.
“percentages and per share data) Three Months Ended March 31, 2026 2025 As Reported (GAAP) Adjusted (Non-GAAP) As Reported (GAAP) Adjusted (Non-GAAP) Total operating revenues $ 992 $ 1,065 $ 912 $ 912 Revenue per available seat mile ("RASM") (¢) 10.11 10.86 9.17 9.17 RASM, stage-length adjusted to 1,000 miles (¢) 9.59 10.29 8.81 8.81 Total operating expenses”
Hinge Health, Inc. reported the first quarter ended March 31, 2026 results: revenue $182.3 million, EPS $0.41. Guidance raised.
“results San Francisco, California – May 5, 2026 – Hinge Health, Inc. (NYSE: HNGE) today announced financial results for the first quarter ended March 31, 2026. “We generated $182 million in revenue this quarter with 47% year-over-year growth, well ahead of expectations, driven by the strength of a platform that automates care delivery, improves member outcomes”
IDEAYA Biosciences, Inc. reported financial results for the first quarter ended March 31, 2026.
“On May 5, 2026, IDEAYA Biosciences, Inc. (the “Company”) announced its financial results for the first quarter ended March 31, 2026.”
JBG SMITH Properties reported financial results for the three months ended March 31, 2026.
“On May 5, 2026, JBG SMITH Properties (the “Company”) announced its financial results for the three months ended March 31, 2026.”
Dianthus Therapeutics, Inc. /DE/ reported financial results for the first quarter ending March 31, 2026.
“On May 5, 2026, Dianthus Therapeutics, Inc. (the “Company”) issued a press release announcing the Company’s financial results for the quarter ended March 31, 2026.”
Southwest Gas Holdings, Inc. updated its quarter ended March 31, 2026 guidance (reaffirmed).
“On May 5, 2026, Southwest Gas Holdings, Inc. released summary financial information to the general public, including the investment community, regarding operating performance for the quarter ended March 31, 2026.”
Select Water Solutions, Inc. reported first quarter ended March 31, 2026 results: revenue $366.0 million, net income $9.4 million. Guidance raised.
“Revenue for the first quarter of 2026 was $366.0 million”
Accel Entertainment, Inc. reported the first quarter ended March 31, 2026 results: revenue $352 million, net income $15 million.
“Revenue increased 9% to $352 million compared to Q1 '25”
GRAIL, Inc. reported first quarter ended March 31, 2026 results: revenue $40.8 million, net income $(93.2) million.
“GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today reported business and financial results for the first quarter of 2026. Total revenue in the first quarter grew 28% year over year to $40.8 million, and Galleri revenue grew 37% year-over-year to $39.8 million. Galleri test volume for the quarter grew 50% year-over-year to more than 56,000. Net loss for the quarter was $93.2 million.”
Granite Point Mortgage Trust Inc. reported quarter ended March 31, 2026 results: net income GAAP net (loss) attributable to common stockholders of $(6.0) million, EPS $(0.13) per basic weighted average common share.
“optimizing our balance sheet, we are positioning the company for future growth." First Quarter 2026 Activity • Recognized GAAP net (loss) attributable to common stockholders of $(6.0) million, or $(0.13) per basic weighted average common share. • Distributable Earnings (Loss) (1) of $(3.0) million, or $(0.06) per basic weighted average common share. •”
Angi Inc. reported Q1 2026 results: revenue $238.2, net income $(9.0) million, EPS $(0.22) per diluted share.
“ANGI INC. SUMMARY RESULTS ($ in millions except per share amounts) Q1 2026 Q1 2025 % Change Revenue $ 238.2 $ 245.9 (3) %”
Ecovyst Inc. reported the first quarter ended March 31, 2026 results: revenue $215.0 million, net income $5.7 million, EPS $0.05. Guidance raised.
“are reported in discontinued operations in the financial statements for all periods presented. First Quarter 2026 Results & Highlights from Continuing Operations • Sales of $215.0 million, up $71.9 million or 50%, compared to $143.1 million in the first quarter of 2025 • Net income of $5.7 million, compared to a net loss of $8.1 million in the year-ago quarter,”
Tempus AI, Inc. reported the quarter ended March 31, 2026 results: revenue $348.1 million, net income ($125.9 million), EPS ($0.70). Guidance raised.
“technology company leading the adoption of AI to advance precision medicine and patient care, today reported financial results for the quarter ended March 31, 2026. • Revenue of $348.1 million, up 36.1% year-over-year • Diagnostics revenue of $261.1 million, representing 34.7% growth year-over-year, driven by Oncology volume growth of 28% • MRD volume was ~6,500 tests”
Arcus Biosciences, Inc. reported financial results for three months ended March 31, 2026.
“On May 5, 2026 , Arcus Biosciences, Inc. issued a press release announcing its financial results for the three months ended March 31, 2026.”
AdaptHealth Corp. reported first quarter ended March 31, 2026 results: revenue $819.8 million, net income $16.0 million. Guidance raised.
“the Company's portfolio around its core Sleep and Respiratory Health businesses. First Quarter Results All comparisons are to the quarter ended March 31, 2025. • Net revenue was $819.8 million compared to $777.9 million, an increase of 5.4%. • Organic revenue growth of 9.1%, with growth across each of the Company’s reportable segments. • Net loss attributable to”
VIEMED HEALTHCARE, INC. reported the three months ended March 31, 2026 results: revenue $75.4 million, net income $2.6 million, EPS $0.06 per diluted share. Guidance raised.
“and updated guidance for the full year ending December 31, 2026. Operational highlights (all dollar amounts are USD): • Net revenues for the quarter ended March 31, 2026 were $75.4 million, representing an increase of $16.3 million, or 28%, over net revenues reported for the comparable quarter ended March 31, 2025. • Net income attributable to Viemed for the”
BrightView Holdings, Inc. reported second quarter ended March 31, 2026 results: revenue $702.9 million, net income $1.7 million. Guidance raised.
“States, today reported unaudited results for the second quarter ended March 31, 2026. SECOND QUARTER FISCAL 2026 SUMMARY • Net service revenues increased 6.1% year-over-year to $702.9 million, including an increase in land maintenance revenue of 4.0%, • Net income decreased $4.7 million year-over-year to $1.7 million, Net income margin of 0.2%, • Adjusted EBITDA 2”
Astera Labs, Inc. reported first quarter of fiscal 2026 ended March 31, 2026 results: revenue $308.4 million, net income $80.3 million, EPS $0.44. Guidance initiated.
“• Revenue of $308.4 million, up 14% sequentially and up 93% year-over-year • GAAP gross margin of 76.3% • GAAP operating income of $61.8 million • GAAP operating margin of 20.1% • GAAP net income of $80.3 million • GAAP diluted net earnings per share of $0.44”
Compass Therapeutics, Inc. reported the quarter ended March 31, 2026 results: revenue $195 million in cash and marketable securities.
“The Phase 1 study for CTX-10726 (PD-1 x VEGF-A bispecific antibody) has also been initiated in the post-checkpoint inhibitor setting, with initial data expected [Q4 2026]. $195 million in cash and marketable securities at Q1 2026, which is expected to fund operations into 2028. BOSTON, May 05, 2026 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX),”
PennyMac Financial Services, Inc. reported financial results for the fiscal quarter ended March 31, 2026.
“Item 2.02 Results of Operations and Financial Condition. On May 5, 2026, PennyMac Financial Services, Inc. (the "Company") issued a press release and a slide presentation announcing its financial results for the fiscal quarter ended March 31, 2026.”
Revolve Group, Inc. reported first quarter ended March 31, 2026 results: revenue $342,880, net income $13,758, EPS $0.20.
“created in partnership with Cardi B.” First Quarter 2026 Financial Summary Three Months Ended March 31, 2026 2025 YoY Change (in thousands, except percentages) Net sales $ 342,880 $ 296,709 16% Gross profit $ 180,615 $ 154,286 17% Gross margin 52.7 % 52.0 % Net income $ 13,758 $ 11,406 21% Adjusted EBITDA (non-GAAP financial measure) $ 21,062 $ 19,299 9%”
Corteva, Inc. reported the quarter ended March 31, 2026 results: revenue $4.90B, net income $725M, EPS $1.07 per share. Guidance reaffirmed.
“INDIANAPOLIS, Ind., May 5, 2026 – Corteva, Inc. (NYSE: CTVA) (“Corteva” or the “Company”) today reported financial results for the first quarter ended March 31, 2026. 1Q 2026 Results Overview Net Sales Inc. from Cont. Ops (After Tax) EPS GAAP $4.90B $725M $1.07 vs. 1Q 2025 11% 9% 10%”
TransMedics Group, Inc. reported the quarter ended March 31, 2026 results: revenue $173.9 million, net income $7.3 million, EPS $0.20 per fully diluted share. Guidance reaffirmed.
“Total revenue of $173.9 million in the first quarter of 2026, a 21% increase compared to the first quarter of 2025 ▪ Net income of $7.3 million or $0.20 per fully diluted share in the first quarter of 2026”
Ardent Health, Inc. reported the first quarter ended March 31, 2026 results: revenue $1,602 million, net income $40 million, EPS $0.28 per diluted share. Guidance reaffirmed.
“period. See the footnotes to the Operating Statistics table of this press release for definitions of the metrics below and a full list of key operating metrics. Total Revenue $1.60 billion 7.0% growth Y/Y Net Income Attributable to Ardent Health $40 million Adjusted EBITDA (1) $124 million 26.3% growth Y/Y Adjusted EBITDAR (1) $166 million Admissions Decrease of”
Postal Realty Trust, Inc. reported Quarter Ended March 31, 2026 results: net income $3.8 million, or $0.11 per diluted share, EPS $0.11 per diluted share. Guidance raised.
“POSTAL REALTY TRUST, INC. REPORTS FIRST QUARTER 2026 RESULTS - Net Income of $0.11 Per Diluted Share - - Increased 2026 AFFO Guidance $0.01 to $1.40 - $1.42 Per Diluted Share”
Mayville Engineering Company, Inc. reported three months ended March 31, 2026 results: revenue $144.8 million, net income ($8.2 million), EPS ($0.40) per diluted share.
“end markets, today announced results for the three-months ended March 31, 2026. FIRST QUARTER 2026 RESULTS (All comparisons versus the prior-year period) ● Net sales of $144.8 million, or +6.8% y/y ● Net loss of $8.2 million, or ($0.40) per diluted share; Non-GAAP Adjusted Diluted EPS of ($0.15) ● Adjusted EBITDA of $6.5 million ● Adjusted EBITDA margin of”
Angel Oak Mortgage REIT, Inc. reported the quarter ended March 31, 2026 results: net income $(7.4) million, EPS $(0.30) per diluted share.
“Q1 2026 GAAP net loss of $(7.4) million, or $(0.30) per diluted share of common stock.”
BELLRING BRANDS, INC. reported second fiscal quarter ended March 31, 2026 results: revenue $598.7 million, net income $33.9 million.
“• Second quarter net sales of $598.7 million, up 2% year-over-year • Operating profit of $66.0 million, net earnings of $33.9 million and Adjusted EBITDA* of $53.8 million, each of which were impacted by a pre-tax $11 million inventory-related charge • Updated fiscal year 2026 net sales outlook of $2.325-$2.365 billion and Adjusted EBITDA* outlook of $315-$335 million”
Momentus Inc. reported fiscal year 2026 results: revenue $10.0 million. Guidance initiated.
“Momentus currently forecasts revenue of $10.0 million in 2026, a 9X increase over $1.1 million reported in our fiscal year 2025 Annual Report filed March 31, 2026.”
First Watch Restaurant Group, Inc. reported thirteen weeks ended March 29, 2026 ("Q1 2026") results: revenue $331.0 million, net income $(2.7) million, EPS $(0.04) per diluted share. Guidance reaffirmed.
“total revenues increased 17.3% to $331.0 million as compared to $282.2 million in the same period of 2025”
CARLSMED, INC. reported first quarter ended March 31, 2026 results: revenue $16.1 million, net income ($8.7) million. Guidance raised.
“set forth by specific reference in such filing. --- EX-99.1 (EX-99.1) --- EX-99.1 Carlsmed ® Reports First Quarter 2026 Financial Results First quarter 2026 revenue of $16.1 million, representing 58% growth year-over-year Full year 2026 revenue guidance raised to $72 million to $77 million CARLSBAD, CALIFORNIA, MAY 5, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc.”
SelectQuote, Inc. reported third quarter ended March 31, 2026 results: revenue $430.9 million, net income $40.2 million. Guidance reaffirmed.
“EX-99.1 (EX-99.1) --- SelectQuote, Inc. Reports Third Quarter of Fiscal Year 2026 Results Third Quarter of Fiscal Year 2026 – Consolidated Earnings Highlights • Revenue of $430.9 million • Net income of $40.2 million • Adjusted EBITDA* of $44.6 million Fiscal Year 2026 Guidance Ranges: • Revenue expected in a range of $1.61 billion to $1.71 billion • Adjusted”
Sphere Entertainment Co. reported first quarter ended March 31, 2026 results: revenue $386.4 million.
“sponsors, including the announcement in April of a new multi-year sponsorship agreement with Evian. For the three months ended March 31, 2026, the Company reported revenues of $386.4 million, an increase of $105.8 million, or 38%, as compared to the prior year quarter. In addition, the Company reported operating income of $7.2 million, an increase of $85.8 million,”
RYTHM, Inc. reported financial results for first quarter ended March 31, 2026.
“On May 5. 2026, RYTHM, Inc. (the “Company”) issued a press release announcing financial results for the quarter ended March 31, 2026.”
Alight, Inc. / Delaware reported first quarter ended March 31, 2026 results: revenue $534 million, net income $(19) million.
“Alight Reports First Quarter 2026 Results – Revenue of $534 million – – Cash provided by operating activities of $79 million; free cash flow of $53 million –”
Lucid Group, Inc. reported first quarter ended March 31, 2026 results: revenue $282.5 million.
“Generated Q1 2026 revenue of $282.5 million, up 20% compared to Q1 2025”
Relay Therapeutics, Inc. reported first quarter ended March 31, 2026 results: revenue 3.0, net income -73.3, EPS -0.41.
“--- EX-99.1 Exhibit 99.1 Relay Therapeutics Reports First Quarter 2026 Financial Results and Corporate Updates FDA Breakthrough Therapy designation granted to zovegalisib for PIK3CA-mutant, HR+/HER2- advanced breast cancer, the Phase 3 ReDiscover-2 trial population in 2L breast cancer Presented zovegalisib doublet data at Phase 3 dose in CDK4/6-experienced”
Ouster, Inc. reported the three months ended March 31, 2026 results: revenue $49 million, net income GAAP net loss of $17 million.
“products and solutions that accelerate customer innovation and unlock new applications that sense, think, act, and learn in the physical world.” First Quarter 2026 Highlights: • $49 million in revenue, up 49% year over year and down 22% sequentially. Total revenue of $62 million in the fourth quarter of 2025 included royalties of approximately $21 million, primarily”
Disc Medicine, Inc. reported the first quarter ended March 31, 2026 results: net income Net loss was $63.5 million for the three months ended March 31, 2026.
“On May 5, 2026, Disc Medicine, Inc. announced its financial results for the first quarter ended March 31, 2026 and provided a corporate update.”
Cipher Digital Inc. reported first quarter ended March 31, 2026 results: revenue $35 million.
“Q1 2026 Revenue of $35 million and Adjusted EBITDA of negative $48 million”
EVgo Inc. reported full year 2026 results: revenue $410 – $470 million. Guidance reaffirmed.
“EVgo is affirming full year 2026 guidance as follows: • Total revenue of $410 – $470 million”
EVgo Inc. reported first quarter ended March 31, 2026 results: net income $(36,980).
“dollars in thousands) Network throughput (GWh) 91 83 10% Revenue $ 109,531 $ 75,287 45% Gross profit $ 12,957 $ 9,323 39% Gross margin 11.8 % 12.4 % (60) bps Net loss $ (36,980) $ (26,227) 41% Adjusted Gross Profit 1 $ 29,633 $ 25,370 17% Adjusted Gross Margin 1 27.1 % 33.7 % (660) bps Adjusted EBITDA 1 $ (7,475) $ (5,929) 26%”
Navitas Semiconductor Corp reported first quarter 2026 ended March 31, 2026 results: revenue $8.6 million.
“Revenue : Total revenue was $8.6 million in the first quarter of 2026”
Sotera Health Co reported the quarter ended March 31, 2026 results: net income net income of $27 million, EPS $0.09 per diluted share. Guidance reaffirmed.
“Q1 2026 net income of $27 million or $0.09 per diluted share, compared to a net loss of $13 million or $0.05 per diluted share in Q1 2025 • Q1 2026 Adjusted EBITDA (1) increased 10.5%, or 6.9% on a constant currency basis • Q1 2026 Adjusted EPS (1) of $0.18 , an increase of 29% per diluted share • Company reaffirms full-year 2026 outlook of 5.0% - 6.5% net revenues growth and 5.5% - 7.0% Adjusted EBITDA growth, both on a constant currency basis”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.